Bed Bath & Beyond (NASDAQ:BBBY) has been assigned a $22.00 price target by equities researchers at Morgan Stanley in a report released on Wednesday. The brokerage currently has a “sell” rating on the retailer’s stock. Morgan Stanley’s price target indicates a potential downside of 4.06% from the stock’s previous close.
A number of other analysts have also recently commented on the company. Robert W. Baird restated a “neutral” rating and issued a $23.00 price objective (down from $28.00) on shares of Bed Bath & Beyond in a research report on Monday, September 18th. Zacks Investment Research cut Bed Bath & Beyond from a “buy” rating to a “hold” rating in a research report on Wednesday, August 30th. Moffett Nathanson started coverage on Bed Bath & Beyond in a research report on Monday, December 4th. They issued a “neutral” rating for the company. KeyCorp cut their price objective on Bed Bath & Beyond from $21.00 to $17.00 and set an “underweight” rating for the company in a research report on Wednesday, November 15th. Finally, ValuEngine upgraded Bed Bath & Beyond from a “hold” rating to a “buy” rating in a research report on Friday, December 1st. Seven investment analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $26.24.
Shares of Bed Bath & Beyond (NASDAQ:BBBY) traded down $0.21 during trading hours on Wednesday, reaching $22.93. The company’s stock had a trading volume of 3,911,600 shares, compared to its average volume of 3,562,814. Bed Bath & Beyond has a one year low of $19.07 and a one year high of $42.35. The firm has a market capitalization of $3,280.00, a P/E ratio of 6.59, a PEG ratio of -3.73 and a beta of 1.10. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.67 and a quick ratio of 0.31.
Several institutional investors and hedge funds have recently modified their holdings of BBBY. Ffcm LLC increased its position in shares of Bed Bath & Beyond by 2,958.6% during the third quarter. Ffcm LLC now owns 4,435 shares of the retailer’s stock worth $104,000 after purchasing an additional 4,290 shares in the last quarter. Bronfman E.L. Rothschild L.P. increased its position in shares of Bed Bath & Beyond by 928.4% during the second quarter. Bronfman E.L. Rothschild L.P. now owns 3,836 shares of the retailer’s stock worth $117,000 after purchasing an additional 3,463 shares in the last quarter. Psagot Investment House Ltd. purchased a new stake in shares of Bed Bath & Beyond during the third quarter worth approximately $217,000. Los Angeles Capital Management & Equity Research Inc. purchased a new stake in shares of Bed Bath & Beyond during the third quarter worth approximately $222,000. Finally, Oldfield Partners LLP increased its position in shares of Bed Bath & Beyond by 381.8% during the third quarter. Oldfield Partners LLP now owns 10,600 shares of the retailer’s stock worth $249,000 after purchasing an additional 8,400 shares in the last quarter. Hedge funds and other institutional investors own 91.72% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This story was published by American Banking and Market News and is the sole property of of American Banking and Market News. If you are viewing this story on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this story can be accessed at https://www.americanbankingnews.com/2017/12/28/bed-bath-beyond-bbby-pt-set-at-22-00-by-morgan-stanley.html.
Bed Bath & Beyond Company Profile
Bed Bath & Beyond Inc is a retailer, which operates under the names Bed Bath & Beyond (BBB), Christmas Tree Shops, Christmas Tree Shops andThat! or andThat! (collectively, CTS), Harmon or Harmon Face Values (collectively, Harmon), buybuy BABY (Baby) and World Market, Cost Plus World Market or Cost Plus (collectively, Cost Plus World Market).
